Biomedical Engineering Reference
In-Depth Information
Kumar G, Wang YC, Co C and Ho CC. 2003. Spatially controlled cell engineering on biomaterials
using polyelectrolytes.
Langmuir
19: 10550-10556.
Larsen CC, Kligman F, Kottke-Marchant K and Marchant RE. 2006. The effect of RGD fluorosur-
factant polymer modification of ePTFE on endothelial cell adhesion, growth, and function.
Biomaterials
27: 4846-4855.
Larsson R, Larm O and Olsson, R. 1983. The search for thromboresistance using immobilized hepa-
rin.
Annals of the New York Academy of Sciences
516: 102-115.
Lee Y, Park JH, Moon HT, Lee DY, Yun JH and Byun Y. 2007. The short-term effects on restenosis and
thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing
polymer.
Biomaterials
28: 1523-1530.
Lin X, Takahashi K, Liu Y and Zamora PO. 2006. Enhancement of cell attachment and tissue inte-
gration by a IKVAV containing multi-domain peptide.
Biochimica et Biophysica Acta
1760:
1403-1410.
Lowe HC, Chesterman CN and Khachigian LM. 2001. Does thrombus contribute to in-stent resteno-
sis in the porcine coronary stent model?
Journal of Thrombosis and Haemostasis
5: 1117-1118.
Lu A and Sipehia R. 2001. Antithrombotic and fibrinolytic system of human endothelial cells seeded
on PTFE: the effects of surface modification of PTFE by ammonia plasma treatment and ECM
protein coatings.
Biomaterials
22: 1439-1446.
Ma Z, He W, Yong T and Ramakrishna S. 2005. Grafting of gelatin on electrospun poly(caprolactone)
nanofibers to improve endothelial cell spreading and proliferation and to control cell orienta-
tion.
Tissue Engineering
11: 1149-1158.
Massia SP and Hubbell JA. 1990. Convalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-
Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates.
Analytical
Biochemistry
187: 292-301.
Massia SP and Hubbell JA. 1991. An RGD spacing of 440 nm is sufficient for integrin alpha V beta
3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation.
The
Journal of Cell Biology
114: 1089-1100.
Mattioli-Belmonte M, Vozzi G, Kyriakidou K, Pulieri E, Lucarini G, Vinci B, Pugnaloni A, Biagini
G and Ahluwalia A. 2008. Rapid-prototyped and salt-leached PLGA scaffolds condition cell
morpho-functional behavior.
Journal of Biomedical Materials Research Part A
85A: 466-476.
Mehran R, Aymong ED, Fischell T, Whitworth HJ, Siegel R, Thomas W, Wong SC and Narasimaiah
R. 2003. Safety of an aspirin-aloneregimen after intracoronary stenting with a heparin-coated
stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone)
study.
Circulation
108: 1078-1083.
Meinhart J, Deustch M and Zilla P. 1997. Eight years of clinical endothelial cell transplantation: clos-
ing the gap between prosthetic grafts and vein grafts.
ASAIO Journal
43: M515-M521.
Michael H, Thomas FMK, Uldis K, Andrejs E, Kari S, Helmut DG, Eberhard G, Robert G, Antonio S,
Hans GR, Peter S and Raimund E. 2003. Heparin-coated stent placement for the treatment of
stenoses in small coronary arteries of symptomatic patients.
Circulation
107: 1265-1270.
Mori T, Kinoshita Y, Watanabe A, Yamaguchi T, Hosokawa K and Honjo H. 2006. Retention of paclitaxel
in cancer cells for 1 week in vivo and in vitro.
Cancer Chemotherapy & Pharmacology
58: 665-672.
Murugesan S, Xie J and Linhardt RJ. 2008. Immobilization of heparin: approaches and applications.
Current Topics in Medicinal Chemistry
8: 80-100.
Nguyen KT, Shaikh N, Shukla KP, Su SH, Eberhart RC and Tang L. 2004. Molecular responses of vas-
cular smooth muscle cells and phagocytes to curcumin-eluting bioresorbable stent materials.
Biomaterials
25: 5333-5346.
Okkema AZ, Yu X-H and Cooper SL. 1991. Physical and blood contacting characteristics of propyl
sulphonate grafted biomer.
Biomaterials
12: 3-12.
Palanzo DA, Zarro DL, Montesano RM, Manley NJ, Quinn M, Elmore BA, Gustafson PA and Castagna
JM. 2001. Effect of Carmeda
®
BioActive Surface coating versus Trillium™ Biopassive Surface
coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass.
Perfusion
16: 279-283.
